People who closely follow a Mediterranean diet carry higher blood levels of two tiny proteins produced inside mitochondria, according to a study of 49 adults published in Frontiers in Nutrition. The proteins, called Humanin and SHMOOSE, belong to a recently discovered class of mitochondrial microproteins that appear to influence aging, metabolism, and heart health. If the connection holds up in larger trials, it would offer a molecular explanation for why olive oil, fish, and vegetables protect against cardiovascular disease even when total calorie intake stays the same.
Why mitochondrial microproteins matter for diet science right now
For decades, researchers have cataloged the benefits of the Mediterranean diet, from lower rates of heart attack to slower cognitive decline, without fully explaining the biology behind those outcomes. The new finding shifts attention to a set of molecules that standard gene-annotation tools long overlooked. Humanin and SHMOOSE are encoded in mitochondrial DNA, but because they are far smaller than conventional proteins, most genomic databases did not flag them as functional gene products until recently.
The study, which analyzed a sub-cohort of 49 participants, found that people with higher Mediterranean diet adherence scores had elevated circulating levels of both microproteins. The researchers also explored a potential interaction between Humanin and Nox2, an enzyme that generates reactive oxygen species in the heart. That interaction, if confirmed in controlled experiments, could help explain how the diet limits cardiac oxidative stress.
A separate line of research supports the idea that mitochondria produce small peptides with outsized metabolic effects. The peptide MOTS-c, identified in work published in Cell Metabolism, promotes metabolic balance and reduces obesity and insulin resistance in cellular and animal models. MOTS-c is not the same molecule as Humanin or SHMOOSE, but all three share a common origin: short open reading frames buried in the mitochondrial genome that were invisible to older sequencing pipelines.
Serine, ribosomes, and a hypothesis connecting diet to microprotein output
One plausible mechanism linking Mediterranean diet components to higher microprotein levels runs through the amino acid serine. Polyphenol-rich foods, including extra-virgin olive oil, leafy greens, and red wine, can alter one-carbon metabolism and increase serine availability in cells. Serine, in turn, feeds into the machinery that mitochondrial ribosomes use to translate their own small genome.
Recent research on the microprotein SMIM26 offers a concrete example of this logic. That protein drives oxidative metabolism through serine-responsive mitochondrial translation, meaning its production ramps up or down depending on how much serine the cell can access. If Humanin and SHMOOSE respond to similar nutrient signals, a diet rich in polyphenols could selectively boost their translation without changing overall caloric intake.
No study has yet measured mitochondrial ribosome activity in human tissue under controlled Mediterranean diet conditions, so the serine hypothesis remains untested in people. Still, the biochemical pieces fit: diet alters nutrient pools, nutrient pools regulate mitochondrial translation, and mitochondrial translation produces microproteins that circulate in the blood and act on distant organs.
What SHMOOSE and Humanin actually do inside cells
SHMOOSE was first characterized in the context of Alzheimer’s disease research. Scientists confirmed its existence by detecting SHMOOSE-derived peptide fragments in mitochondria using mass spectrometry, establishing it as a genuine translated product rather than a computational artifact. A genetic variant in the SHMOOSE-encoding region has been linked to changes in brain structure and Alzheimer’s risk, though the exact protective or harmful direction depends on the specific mutation.
Humanin, discovered earlier, has been studied more extensively. It appears to protect cells against stress-induced death and has shown anti-inflammatory properties in animal models. The new diet study’s proposal that Humanin interacts with Nox2 adds a cardiovascular dimension: by dampening reactive oxygen species in heart tissue, Humanin could reduce the kind of oxidative damage that accumulates in coronary artery disease.
Both molecules belong to a broader family of mitochondrial-derived peptides that researchers have only begun to catalog. Reviews of the field note that experimental tools such as ribosome profiling and advanced proteomics have revealed dozens of previously unknown microproteins localized to mitochondria, many with defined roles in energy production, stress response, and programmed cell death.
Gaps in the evidence and what to watch next
The most obvious limitation is sample size. A sub-cohort of 49 people can detect associations but cannot establish cause and effect. No larger replication cohort or longitudinal follow-up has been reported, so it is unclear whether the microprotein differences persist over months or years of dietary adherence, or whether they fluctuate quickly with short-term changes in eating patterns. Without repeated measurements, researchers cannot yet say if Humanin and SHMOOSE act as stable biomarkers of long-term lifestyle or as fast-moving indicators of recent meals.
Another gap is the lack of mechanistic data in humans. The current work measured circulating protein levels but did not directly test how much of each microprotein was being produced in specific tissues such as heart, liver, or brain. Nor did it manipulate diet in a randomized way. Participants were observed rather than assigned to Mediterranean or non-Mediterranean eating patterns, leaving room for confounding factors like exercise, sleep, or unmeasured supplements that might also influence mitochondrial function.
The interaction between Humanin and Nox2, while intriguing, remains hypothetical. The study inferred this potential link from correlations and prior biochemical knowledge about oxidative stress pathways. Demonstrating a causal connection will require experiments in cells and animal models where Humanin levels can be precisely controlled and Nox2 activity monitored in real time. Only then will it be possible to determine whether boosting Humanin directly reduces the damaging reactive oxygen species that contribute to heart disease.
There are also unanswered questions about safety and context. If future trials show that Mediterranean-style eating consistently elevates Humanin and SHMOOSE, some groups may be tempted to develop supplements or injectable versions of these peptides. Yet microproteins often have multiple roles, and raising their levels outside of the nuanced control of mitochondrial translation could produce unintended effects. For instance, a molecule that protects neurons from death in one setting might interfere with necessary cell turnover in another.
Future research is likely to move in three directions. First, larger population studies could test whether people with naturally higher levels of mitochondrial microproteins experience fewer cardiovascular events or slower cognitive decline over time. Second, controlled feeding trials could compare a tightly defined Mediterranean diet against other eating patterns while tracking microprotein levels, mitochondrial function, and clinical markers such as blood pressure and cholesterol. Third, basic science labs will continue mapping how nutrients like serine, polyphenols, and fatty acids regulate mitochondrial translation and microprotein output at the molecular level.
For now, the findings should not be interpreted as a license to ignore traditional dietary advice. The same foods that appear to raise Humanin and SHMOOSE-extra-virgin olive oil, nuts, legumes, whole grains, fruits, vegetables, and modest amounts of fish-are already recommended for their well-established benefits on blood lipids, inflammation, and vascular health. The emerging microprotein story simply adds another layer of potential explanation, suggesting that mitochondria may act as nutrient sensors that convert dietary patterns into protective signals distributed throughout the body.
If that model holds up, it could change how clinicians think about nutrition. Instead of focusing only on macronutrients like fats and carbohydrates, future guidelines might also consider how specific food combinations influence mitochondrial translation and microprotein production. Blood tests for molecules such as Humanin, SHMOOSE, and MOTS-c could one day complement cholesterol panels, providing a more direct readout of how a person’s cells are responding to their diet. Until such tools are validated, however, the most practical takeaway is a familiar one: eating in line with Mediterranean principles remains one of the most evidence-backed ways to support heart and brain health, and mitochondrial microproteins may be part of the reason why.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
